Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

British Journal of Cancer, Published online: 13 November 2019; doi:10.1038/s41416-019-0611-6Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research